Pharmaceutical formulation containing an LTB4 antagonist, method for the production thereof, and use thereof

Details for Australian Patent Application No. 2004285271 (hide)

Owner Boehringer Ingelheim International GmbH

Inventors Weber, Karl; Moll, Siglinde; Brauns, Ulrich; Bock, Thomas

Agent Davies Collison Cave

Pub. Number AU-A-2004285271

PCT Pub. Number WO2005/041855

Priority 103 50 528.8 29.10.03 DE

Filing date 23 October 2004

Wipo publication date 12 May 2005

International Classifications

A61K 9/10 (2006.01) Medicinal preparations characterised by special physical form - Dispersions

A61K 9/14 (2006.01) Medicinal preparations characterised by special physical form - Particulate form, e.g. powders

A61K 9/16 (2006.01) Medicinal preparations characterised by special physical form - Agglomerates

A61K 31/155 (2006.01) - Amidines (), e.g. guanidine (HNC(NH)NH), isourea (HNC(OH)NH), isothiourea (HNC(SH)NH)

Event Publications

8 June 2006 PCT application entered the National Phase

  PCT publication WO2005/041855 Priority application(s): WO2005/041855

20 May 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004285273-Use of extracts from the pelargonium species

2004285269-Herbicidally active agent